Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2317 Views
-
Last post by NHE
-
- 6 Replies
- 6762 Views
-
Last post by ElliotB
-
- 0 Replies
- 1379 Views
-
Last post by NHE
-
- 0 Replies
- 3440 Views
-
Last post by NHE
-
- 1 Replies
- 1032 Views
-
Last post by NHE
-
- 1 Replies
- 1529 Views
-
Last post by NHE
-
- 11 Replies
- 3409 Views
-
Last post by NHE
-
- 0 Replies
- 3165 Views
-
Last post by NHE
-
- 0 Replies
- 1462 Views
-
Last post by NHE